Distant site effects of ingested prebiotics

Nutrients

Volumn 8, Issue 9, 2016, Pages

  Collins, Stephanie ^a   Reid, Gregor ^a,b  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b LAWSON HEALTH RESEARCH INSTITUTE   (Canada)

Author keywords

Bone; Brain; Cardiovascular; Immune; Microbiome; Prebiotics

Indexed keywords

CORTICOSTERONE; CORTICOTROPIN; INULIN; LIPID; PREBIOTIC AGENT; PROBIOTIC AGENT;

ANXIETY; ATTENTIONAL BIAS; AUTISM; BONE DENSITY; BONE REGENERATION; BONE REMODELING; BONE STRENGTH; BRAIN FUNCTION; CALCIUM ABSORPTION; CALCIUM INTAKE; CALCIUM TRANSPORT; COGNITION; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DYSBIOSIS; HEPATIC ENCEPHALOPATHY; HUMAN; HYPERAMMONEMIA; IMMUNIZATION; INTESTINE FLORA; INTESTINE MUCOSA PERMEABILITY; LEARNING; MAGNESIUM INTAKE; MEMORY; MENTAL HEALTH; MOOD DISORDER; OSTEOLYSIS; OSTEOPENIA; OSTEOPOROSIS; POSTMENOPAUSE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK FACTOR; SKIN FUNCTION; WATER RETENTION; ANIMAL; BACTERIUM; BLOOD; CLASSIFICATION; FERMENTATION; GASTROINTESTINAL TRACT; HOST PATHOGEN INTERACTION; IMMUNE SYSTEM; METABOLISM; MICROBIOLOGY; NERVOUS SYSTEM; PATHOPHYSIOLOGY; SKIN;

ANIMALS; BACTERIA; BONE DENSITY; BONE REMODELING; COGNITION; FERMENTATION; GASTROINTESTINAL MICROBIOME; GASTROINTESTINAL TRACT; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNE SYSTEM; LIPIDS; NERVOUS SYSTEM; PREBIOTICS; SKIN;

EID: 85015993992     PISSN: None     EISSN: 20726643     Source Type: Journal    
DOI: 10.3390/nu8090523     Document Type: Review

References (138)

1. Turroni, F.; Ventura, M.; Buttó, L.F.; Duranti, S.; O’Toole, P.W.; Motherway, M.O.; van Sinderen, D. Molecular dialogue between the human gut microbiota and the host: A Lactobacillus and Bifidobacterium perspective. Cell. Mol. Life Sci. 2014, 71, 183-203. [CrossRef] [PubMed]
2. Gibson, G.R.; Roberfroid, M.B. Dietary modulation of the human colonic microbiota: Introducing the concept of prebiotics. J. Nutr. 1995, 125, 1401-1412. [PubMed]
3. Gibson, G.R.; Probert, H.M.; Loo, J.V.; Rastall, R.A.; Roberfroid, M.B. Dietary modulation of the human colonic microbiota: Updating the concept of prebiotics. Nutr. Res. Rev. 2004, 17, 259-275. [CrossRef] [PubMed]
4. Patel, S.; Goyal, A. Functional oligosaccharides: Production, properties and applications. World J. Microbiol. Biotechnol. 2011, 27, 1119-1128. [CrossRef]
5. Roberfroid, M.B. Health benefits of non-digestible oligosaccharides. Adv. Exp. Med. Biol. 1997, 427, 211-219. [PubMed]
6. Hernot, D.C.; Boileau, T.W.; Bauer, L.L.; Middelbos, I.S.; Murphy, M.R.; Swanson, K.S.; Fahey, G.C. In vitro fermentation profiles, gas production rates, and microbiota modulation as affected by certain fructans, galactooligosaccharides, and polydextrose. J. Agric. Food Chem. 2009, 57, 1354-1361. [CrossRef] [PubMed]
7. Zhou, Z.; Zhang, Y.; Zheng, P.; Chen, X.; Yang, Y. Starch structure modulates metabolic activity and gut microbiota profile. Anaerobe 2013, 24, 71-78. [CrossRef] [PubMed]
8. Ríos-Covián, D.; Ruas-Madiedo, P.; Margolles, A.; Gueimonde, M.; de los Reyes-Gavilán, C.G.; Salazar, N. Intestinal short chain fatty acids and their link with diet and human health. Microb. Physiol. Metab. 2016, 7, 185. [CrossRef] [PubMed]
9. Hamer, H.M.; Jonkers, D.; Venema, K.; Vanhoutvin, S.; Troost, F.J.; Brummer, R.J. Review article: The role of butyrate on colonic function. Aliment. Pharmacol. Ther. 2008, 27, 104-119. [CrossRef] [PubMed]
10. Den Besten, G.; van Eunen, K.; Groen, A.K.; Venema, K.; Reijngoud, D.J.; Bakker, B.M. The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism. J. Lipid Res. 2013, 54, 2325-2340. [CrossRef] [PubMed]
11. Eiwegger, T.; Stahl, B.; Haidl, P.; Schmitt, J.; Boehm, G.; Dehlink, E.; Urbanek, R.; Szépfalusi, Z. Prebiotic oligosaccharides: In vitro evidence for gastrointestinal epithelial transfer and immunomodulatory properties. Pediatr. Allergy Immunol. 2010, 21, 1179-1188. [CrossRef] [PubMed]
12. Kanis, J.A. On behalf of the World Health Organization Scientific Group. In Assessment of Osteoporosis at the Primary Health-Care Level; Technical Report by the World Health Organization Collaborating Centre for Metabolic Bone Diseases; University of Sheffield: Sheffield, UK, 2007; p. 337.
13. Chonan, O.; Watanuki, M. Effect of galactooligosaccharides on calcium absorption in rats. J. Nutr. Sci. Vitaminol. 1995, 41, 95-104. [CrossRef] [PubMed]
14. Weaver, C.M.; Martin, B.R.; Nakatsu, C.H.; Armstrong, A.P.; Clavijo, A.; McCabe, L.D.; McCabe, G.P.; Duignan, S.; Schoterman, M.H.; van den Heuvel, E.G. Galactooligosaccharides improve mineral absorption and bone properties in growing rats through gut fermentation. J. Agric. Food Chem. 2011, 59, 6501-6510. [CrossRef] [PubMed]
15. Legette, L.L.; Lee, W.; Martin, B.R.; Story, J.A.; Campbell, J.K.; Weaver, C.M. Prebiotics enhance magnesium absorption and inulin-based fibers exert chronic effects on calcium utilization in a postmenopausal rodent model. J. Food Sci. 2012, 77, 88-94. [CrossRef] [PubMed]
16. Zafar, T.A.; Weaver, C.M.; Zhao, Y.; Martin, B.R.; Wastney, M.E. Nondigestible oligosaccharides increase calcium absorption and suppress bone resorption in ovariectomized rats. J. Nutr. 2004, 134, 399-402. [PubMed]
17. Chonan, O.; Matsumoto, K.; Watanuki, M. Effect of galactooligosaccharides on calcium absorption and preventing bone loss in ovariectomized rats. Biosci. Biotechnol. Biochem. 1995, 59, 236-239. [CrossRef] [PubMed]
18. Mitamura, R.; Hara, H. Prolonged feeding of difructose anhydride 3 increases strength and mineral concentrations of the femur in ovariectomized rats. Br. J. Nutr. 2005, 94, 268-274. [CrossRef] [PubMed]
19. Mitamura, R.; Hara, H.; Aoyama, Y.; Chiji, H. Supplemental feeding of difructose anhydride III restores calcium absorption impaired by ovariectomy in rats. J. Nutr. 2002, 132, 3387-3393. [PubMed]
20. Coxam, V. Current data with inulin-type fructans and calcium, targeting bone health in adults. J. Nutr. 2007, 137, 2527S-2533S. [PubMed]
21. McCabe, L.; Britton, R.A.; Parameswaran, N. Prebiotic and probiotic regulation of bone health: Role of the intestine and its microbiome. Curr. Osteoporos. Rep. 2015, 13, 363-371. [CrossRef] [PubMed]
22. Scholz-Ahrens, K.E.; Ade, P.; Marten, B.; Weber, P.; Timm, W.; Açil, Y.; Glüer, C.C.; Schrezenmeir, J. Prebiotics, probiotics, and synbiotics affect mineral absorption, bone mineral content, and bone structure. J. Nutr. 2007, 137, 838S-846S. [PubMed]
23. Holloway, L.; Moynihan, S.; Abrams, S.A.; Kent, K.; Hsu, A.R.; Friedlander, A.L. Effects of oligofructose-enriched inulin on intestinal absorption of calcium and magnesium and bone turnover markers in postmenopausal women. Br. J. Nutr. 2007, 97, 365-372. [CrossRef] [PubMed]
24. Tahiri, M.; Tressol, J.C.; Arnaud, J.; Bornet, F.R.; Bouteloup-Demange, C.; Feillet-Coudray, C.; Brandolini, M.; Ducros, V.; Pépin, D.; Brouns, F.; et al. Effect of short-chain fructooligosaccharides on intestinal calcium absorption and calcium status in postmenopausal women: A stable-isotope study. Am. J. Clin. Nutr. 2003, 77, 449-457. [PubMed]
25. Kim, Y.Y.; Jang, K.H.; Kang, S.A.; Ha, W.K.; Lee, E.Y.; Cho, Y.H.; Choue, R.W. The effect of chicory fructan fiber on calcium absorption and bone metabolism in Korean postmenopausal women. Nutr. Sci. 2004, 7, 151-157.
26. Van den Heuvel, E.G.; Schoterman, M.H.; Muijs, T. Transgalactooligosaccharides stimulate calcium absorption in postmenopausal women. J. Nutr. 2000, 130, 2938-2942. [PubMed]
27. Van den Heuvel, E.G.; Muijs, T.; van Dokkum, W.; Schaafsma, G. Lactulose stimulates calcium absorption in postmenopausal women. J. Bone Miner. Res. 1999, 14, 1211-1216. [CrossRef] [PubMed]
28. Van den Heuvel, E.G.; Schaafsma, G.; Muys, T.; van Dokkum, W. Nondigestible oligosaccharides do not interfere with calcium and nonheme-iron absorption in young, healthy men. Am. J. Clin. Nutr. 1998, 67, 445-451. [PubMed]
29. Abrams, S.A.; Griffin, I.J.; Hawthorne, K.M.; Liang, L.; Gunn, S.K.; Darlington, G.; Ellis, K.J. A combination of prebiotic short- and long-chain inulin-type fructans enhances calcium absorption and bone mineralization in young adolescents. Am. J. Clin. Nutr. 2005, 82, 471-476. [PubMed]
30. Griffin, I.J.; Davila, P.M.; Abrams, S.A. Non-digestible oligosaccharides and calcium absorption in girls with adequate calcium intakes. Br. J. Nutr. 2002, 87, S187-S191. [CrossRef] [PubMed]
31. Van den Heuvel, E.G.; Muys, T.; van Dokkum, W.; Schaafsma, G. Oligofructose stimulates calcium absorption in adolescents. Am. J. Clin. Nutr. 1999, 69, 544-548. [PubMed]
32. Slevin, M.M.; Allsopp, P.J.; Magee, P.J.; Bonham, M.P.; Naughton, V.R.; Strain, J.J.; Duffy, M.E.; Wallace, J.M.; Mc Sorley, E.M. Supplementation with calcium and short-chain fructo-oligosaccharides affects markers of bone turnover but not bone mineral density in postmenopausal women. J. Nutr. 2014, 144, 297-304. [CrossRef] [PubMed]
33. Reid, G.; Younes, J.A.; Van der Mei, H.C.; Gloor, G.B.; Knight, R.; Busscher, H.J. Microbiota restoration: Natural and supplemented recovery of human microbial communities. Nat. Rev. Microbiol. 2011, 9, 27-38. [CrossRef] [PubMed]
34. Pérez-Conesa, D.; López, G.; Ros, G. Effects of probiotic, prebiotic and synbiotic follow-up infant formulas on large intestine morphology and bone mineralisation in rats. J. Sci. Food Agric. 2007, 87, 1059-1068. [CrossRef]
35. Zdu nczyk, Z.; Juskiewicz, J.; Wróblewska, M.; Król, B. Physiological effects of lactulose and inulin in the caecum of rats. Arch. Anim. Nutr. 2004, 58, 89-98. [CrossRef] [PubMed]
36. Trinidad, T.P.; Wolever, T.M.; Thompson, L.U. Effect of acetate and propionate on calcium absorption from the rectum and distal colon of humans. Am. J. Clin. Nutr. 1996, 63, 574-578. [PubMed]
37. Trinidad, T.P.; Wolever, T.M.; Thompson, L.U. Effects of calcium concentration, acetate, and propionate on calcium absorption in the human distal colon. Nutrition 1999, 15, 529-533. [CrossRef]
38. Mitsuoka, T. Intestinal flora and aging. Nutr. Rev. 1992, 50, 438-446. [PubMed]
39. Kim, E.K.; Ha, A.W.; Choi, E.O.; Ju, S.Y. Analysis of Kimchi, vegetable and fruit consumption trends among Korean adults: Data from the Korea National Health and Nutrition Examination Survey (1998-2012). Nutr. Res. Pract. 2016, 10, 188-197. [CrossRef] [PubMed]
40. Imhann, F.; Bonder, M.J.; Vila, A.V.; Fu, J.; Mujagic, Z.; Vork, L.; Tigchelaar, E.F.; Jankipersadsing, S.A.; Cenit, M.C.; Harmsen, H.J.; et al. Proton pump inhibitors affect the gut microbiome. Gut 2016, 65, 740-748.[CrossRef] [PubMed]
41. Leontiadis, G.I.; Moayyedi, P. Proton pump inhibitors and risk of bone fractures. Curr. Treat. Options Gastroenterol. 2014, 12, 414-423. [CrossRef] [PubMed]
42. Ozdil, K.; Kahraman, R.; Sahin, A.; Calhan, T.; Gozden, E.H.; Akyuz, U.; Erer, B.; Sokmen, M.H. Bone density in proton pump inhibitors users: A prospective study. Rheumatol. Int. 2013, 33, 2255-2260. [CrossRef] [PubMed]
43. Van Kraaij, D.J.; Jansen, R.W.; Gribnau, F.W.; Hoefnagels, W.H. Loop diuretics in patients aged 75 years or older: General practitioners’ assessment of indications and possibilities for withdrawal. Eur. J. Clin. Pharmacol. 1998, 54, 323-327. [CrossRef] [PubMed]
44. Overman, R.A.; Yeh, J.Y.; Deal, C.L. Prevalence of oral glucocorticoid usage in the United States: A general population perspective. Arthritis Care Res. 2013, 65, 294-298. [CrossRef] [PubMed]
45. Holm, J.P.; Hyldstrup, L.; Jensen, J.B. Time trends in osteoporosis risk factor profiles: A comparative analysis of risk factors, comorbidities, and medications over twelve years. Endocrine 2016. [CrossRef] [PubMed]
46. Gaman, A.; Kuo, B. Neuromodulatory processes of the brain-gut axis. Neuromodulation 2008, 11, 249-259. [CrossRef] [PubMed]
47. Grenham, S.; Clarke, G.; Cryan, J.F.; Dinan, T.G. Brain-gut-microbe communication in health and disease. Gastrointest. Sci. 2011, 2, 94. [CrossRef] [PubMed]
48. Liu, X.; Cao, S.; Zhang, X. Modulation of gut microbiota-brain axis by probiotics, prebiotics, and diet. J. Agric. Food Chem. 2015, 63, 7885-7895. [CrossRef] [PubMed]
49. Forsythe, P.; Bienenstock, J.; Kunze, W.A. Vagal pathways for microbiome-brain-gut axis communication. Adv. Exp. Med. Biol. 2014, 817, 115-133. [PubMed]
50. Bravo, J.A.; Forsythe, P.; Chew, M.V.; Escaravage, E.; Savignac, H.M.; Dinan, T.G.; Bienenstock, J.; Cryan, J.F. Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve. Proc. Natl. Acad. Sci. USA 2011, 108, 16050-16055. [CrossRef] [PubMed]
51. Savignac, H.M.; Corona, G.; Mills, H.; Chen, L.; Spencer, J.P.; Tzortzis, G.; Burnet, P.W. Prebiotic feeding elevates central brain derived neurotrophic factor, N-methyl-d-aspartate receptor subunits and d-serine. Neurochem. Int. 2013, 63, 756-764. [CrossRef] [PubMed]
52. Williams, S.; Chen, L.; Savignac, H.M.; Tzortzis, G.; Anthony, D.C.; Burnet, P.W. Neonatal prebiotic (BGOS) supplementation increases the levels of synaptophysin, GluN2A-subunits and BDNF proteins in the adult rat hippocampus. Synapse 2016, 70, 121-124. [CrossRef] [PubMed]
53. Sudo, N.; Chida, Y.; Aiba, Y.; Sonoda, J.; Oyama, N.; Yu, X.N.; Kubo, C.; Koga, Y. Postnatal microbial colonization programs the hypothalamic-pituitary-adrenal system for stress response in mice. J. Physiol. 2004, 558, 263-275. [CrossRef] [PubMed]
54. Nelson, E.D.; Ramberg, J.E.; Best, T.; Sinnott, R.A. Neurologic effects of exogenous saccharides: A review of controlled human, animal, and in vitro studies. Nutr. Neurosci. 2012, 15, 149-162. [CrossRef] [PubMed]
55. Messaoudi, M.; Rozan, P.; Nejdi, A.; Hidalgo, S.; Desor, D. Behavioural and cognitive effects of oligofructose-enriched inulin in rats. Br. J. Nutr. 2005, 93, S27-S30. [CrossRef] [PubMed]
56. Waworuntu, R.; Hain, H.; Chang, Q.; Thiede, L.; Hanania, T.; Berg, B. Dietary prebiotics improve memory and social interactions while reducing anxiety when provided early in life to normally developing rodents. FASEB J. 2014, 28, 63-75.
57. Sakai, F.; Ikeuchi, Y.; Urashima, T.; Fujihara, M.; Ohtsuki, K.; Yanahira, S. Effects of feeding sialyllactose and galactosylated N-acetylneuraminic acid on swimming learning ability and brain lipid composition in adult rats. J. Appl. Glycosci. 2006, 53, 249-254. [CrossRef]
58. Wang, B.; Yu, B.; Karim, M.; Hu, H.; Sun, Y.; McGreevy, P.; Petocz, P.; Held, S.; Brand-Miller, J. Dietary sialic acid supplementation improves learning and memory in piglets. Am. J. Clin. Nutr. 2007, 85, 561-569. [PubMed]
59. Smith, A.P. The concept of well-being: Relevance to nutrition research. Br. J. Nutr. 2005, 93, S1-S5. [CrossRef] [PubMed]
60. Smith, A.P.; Sutherland, D.; Hewlett, P. An investigation of the acute effects of oligofructose-enriched inulin on subjective wellbeing, mood and cognitive performance. Nutrients 2015, 7, 8887-8896. [CrossRef] [PubMed]
61. Best, T.; Kemps, E.; Bryan, J. Saccharide effects on cognition and well-being in middle-aged adults: A randomized controlled trial. Dev. Neuropsychol. 2009, 35, 66-80. [CrossRef] [PubMed]
62. Best, T.; Howe, P.; Bryan, J.; Buckley, J.; Scholey, A. Acute effects of a dietary non-starch polysaccharide supplement on cognitive performance in healthy middle-aged adults. Nutr. Neurosci. 2015, 18, 76-86. [CrossRef] [PubMed]
63. Best, T.; Kemps, E.; Bryan, J. Association between dietary saccharide intake and self-reported memory performance in middle-aged adults. Br. J. Nutr. 2009, 101, 93-99. [CrossRef] [PubMed]
64. Han, H.S.; Jang, J.H.; Jang, J.H.; Choi, J.S.; Kim, Y.J.; Lee, C.; Lim, S.H.; Lee, H.K.; Lee, J. Water extract of Triticum aestivum L. and its components demonstrate protective effect in a model of vascular dementia. J. Med. Food 2010, 13, 572-578. [CrossRef] [PubMed]
65. Van den Berg, J.P.; Westerbeek, E.A.M.; Bröring-Starre, T.; Garssen, J.; van Elburg, R.M. Neurodevelopment of preterm infants at 24 months after neonatal supplementation of a prebiotic mix: A randomized trial. J. Pediatr. Gastroenterol. Nutr. 2016, 63, 270-276. [CrossRef] [PubMed]
66. Heijtz, R.D.; Wang, S.; Anuar, F.; Qian, Y.; Björkholm, B.; Samuelsson, A.; Hibberd, M.L.; Forssberg, H.; Pettersson, S. Normal gut microbiota modulates brain development and behavior. Proc. Natl. Acad. Sci. USA 2011, 108, 3047-3052. [CrossRef] [PubMed]
67. Neufeld, K.M.; Kang, N.; Bienenstock, J.; Foster, J.A. Reduced anxiety-like behavior and central neurochemical change in germ-free mice. Neurogastroenterol. Motil. 2011, 23, 255-264, e119. [CrossRef] [PubMed]
68. Mudd, A.T.; Alexander, L.S.; Berding, K.; Waworuntu, R.V.; Berg, B.M.; Donovan, S.M.; Dilger, R.N. Dietary prebiotics, milk fat globule membrane, and lactoferrin affects structural neurodevelopment in the young piglet. Front. Pediatr. 2016, 4, 4. [CrossRef] [PubMed]
69. Berding, K.; Wang, M.; Monaco, M.H.; Alexander, L S.; Mudd, A.T.; Chichlowski, M.; Waworuntu, R.V.; Berg, B.M.; Miller, M.J.; Dilger, R.N.; et al. Prebiotics and bioactive milk fractions affect gut development, microbiota and neurotransmitter expression in piglets. J. Pediatr. Gastroenterol. Nutr. 2016, in press. [CrossRef] [PubMed]
70. Tarr, A.J.; Galley, J.D.; Fisher, S.E.; Chichlowski, M.; Berg, B.M.; Bailey, M.T. The prebiotics 30sialyllactose and 60sialyllactose diminish stressor-induced anxiety-like behavior and colonic microbiota alterations: Evidence for effects on the gut-brain axis. Brain. Behav. Immun. 2015, 50, 166-177. [CrossRef] [PubMed]
71. Schmidt, K.; Cowen, P.J.; Harmer, C.J.; Tzortzis, G.; Errington, S.; Burnet, P.W. Prebiotic intake reduces the waking cortisol response and alters emotional bias in healthy volunteers. Psychopharmacology 2015, 232, 1793-1801. [CrossRef] [PubMed]
72. Bercik, P.; Denou, E.; Collins, J.; Jackson, W.; Lu, J.; Jury, J.; Deng, Y.; Blennerhassett, P.; Macri, J.; McCoy, K.D.; et al. The intestinal microbiota affect central levels of brain-derived neurotropic factor and behavior in mice. Gastroenterology 2011, 141, 599-609. [CrossRef] [PubMed]
73. Buie, T.; Campbell, D.B.; Fuchs, G.J.; Furuta, G.T.; Levy, J.; VandeWater, J.; Whitaker, A.H.; Atkins, D.; Bauman, M.L.; Beaudet, A.L.; et al. Evaluation, diagnosis, and treatment of gastrointestinal disorders in individuals with ASDs: A consensus report. Pediatrics 2010, 125, S1-S18. [CrossRef] [PubMed]
74. Adams, J.B.; Johansen, L.J.; Powell, L.D.; Quig, D.; Rubin, R.A. Gastrointestinal flora and gastrointestinal status in children with autism—comparisons to typical children and correlation with autism severity. BMC Gastroenterol. 2011, 11, 22. [CrossRef] [PubMed]
75. De Angelis, M.; Piccolo, M.; Vannini, L.; Siragusa, S.; De Giacomo, A.; Serrazzanetti, D.I.; Cristofori, F.; Guerzoni, M.E.; Gobbetti, M.; Francavilla, R. Fecal microbiota and metabolome of children with autism and pervasive developmental disorder not otherwise specified. PLoS ONE 2013, 8, e76993.
76. Lefranc-Millot, C.; Guérin-Deremaux, L.; Wils, D.; Neut, C.; Miller, L.E.; Saniez-Degrave, M.H. Impact of a resistant dextrin on intestinal ecology: How altering the digestive ecosystem with NUTRIOSE®, a soluble fibre with prebiotic properties, may be beneficial for health. J. Int. Med. Res. 2012, 40, 211-224. [CrossRef] [PubMed]
77. Nankova, B.B.; Agarwal, R.; MacFabe, D.F.; La Gamma, E.F. Enteric bacterial metabolites propionic and butyric acid modulate gene expression, including CREB-dependent catecholaminergic neurotransmission, in PC12 cells-possible relevance to autism spectrum disorders. PLoS ONE 2014, 9, e103740. [CrossRef] [PubMed]
78. Hsiao, E.Y.; McBride, S.W.; Hsien, S.; Sharon, G.; Hyde, E.R.; McCue, T.; Codelli, J.A.; Chow, J.; Reisman, S.E.; Petrosino, J.F.; et al. Microbiota modulate behavioral and physiological abnormalities associated with neurodevelopmental disorders. Cell 2013, 155, 1451-1463. [CrossRef] [PubMed]
79. Gloor, G.B.; Reid, G. Compositional analysis: A valid approach to analyze microbiome high-throughput sequencing data. Can. J. Microbiol. 2016, 1-12. [CrossRef] [PubMed]
80. Ong, J.P.; Aggarwal, A.; Krieger, D.; Easley, K.A.; Karafa, M.T.; Van Lente, F.; Arroliga, A.C.; Mullen, K.D. Correlation between ammonia levels and the severity of hepatic encephalopathy. Am. J. Med. 2003, 114, 188-193. [CrossRef]
81. Müller, J.B.; Guggenheim, P.; Haemmerli, U.P. Treatment of chronic portal-systemic encephalopathy with lactulose. Lancet 1966, 287, 890-893. [CrossRef]
82. Prasad, S.; Dhiman, R.K.; Duseja, A.; Chawla, Y.K.; Sharma, A.; Agarwal, R. Lactulose improves cognitive functions and health-related quality of life in patients with cirrhosis who have minimal hepatic encephalopathy. Hepatology 2007, 45, 549-559. [CrossRef] [PubMed]
83. Gluud, L.L.; Vilstrup, H.; Morgan, M.Y. Dietary prebiotics, milk fat globule membrane, and lactoferrin affects structural neurodevelopment in the young piglet. Cochrane Database Syst. Rev. 2016. [CrossRef]
84. Shukla, S.; Shukla, A.; Mehboob, S.; Guha, S. Meta-analysis: The effects of gut flora modulation using prebiotics, probiotics and synbiotics on minimal hepatic encephalopathy. Aliment. Pharmacol. Ther. 2011, 33, 662-671. [CrossRef] [PubMed]
85. Elkington, S.G.; Floch, M.H.; Conn, H.O. Lactulose in the treatment of chronic portal-systemic encephalopathy. N. Engl. J. Med. 1969, 281, 408-412. [CrossRef] [PubMed]
86. Weber, F.L. Lactulose and combination therapy of hepatic encephalopathy: The role of the intestinal microflora. Dig. Dis. Basel Switz. 1996, 14, 53-63. [CrossRef]
87. Blanc, P.; Daures, J.P.; Rouillon, J.M.; Peray, P.; Pierrugues, R.; Larrey, D.; Gremy, F.; Michel, H. Lactitol or lactulose in the treatment of chronic hepatic encephalopathy: Results of a meta-analysis. Hepatol. Baltim. Md. 1992, 15, 222-228. [CrossRef]
88. Cammà, C.; Fiorello, F.; Tinè, F.; Marchesini, G.; Fabbri, A.; Pagliaro, L. Lactitol in treatment of chronic hepatic encephalopathy. Dig. Dis. Sci. 1993, 38, 916-922. [CrossRef] [PubMed]
89. Clarke, S.T.; Green-Johnson, J.M.; Brooks, S.P.J.; Ramdath, D.D.; Bercik, P.; Avila, C.; Inglis, G.D.; Green, J.; Yanke, L.J.; Selinger, L.B.; Kalmokoff, M. 2-1 fructan supplementation alters host immune responses in a manner consistent with increased exposure to microbial components: Results from a double-blinded, randomised, cross-over study in healthy adults. Br. J. Nutr. 2016, 115, 1748-1759. [CrossRef] [PubMed]
90. Lomax, A.R.; Cheung, L.V.Y.; Tuohy, K.M.; Noakes, P.S.; Miles, E.A.; Calder, P.C. 2-1 fructans have a bifidogenic effect in healthy middle-aged human subjects but do not alter immune responses examined in the absence of an in vivo immune challenge: Results from a randomised controlled trial. Br. J. Nutr. 2012, 108, 1818-1828. [CrossRef] [PubMed]
91. Firmansyah, A.; Pramita, G.; Carrie Fassler, A.; Haschke, F.; Link-Amster, H. Improved humoral response to measles vaccine in infants receiving infant cereal with fructo-oligosaccharides. J. Pediatr. Gastroenterol. Nutr. 2001, 31, A521.
92. Lomax, A.R.; Cheung, L.V.; Noakes, P.S.; Miles, E.A.; Calder, P.C. Inlin-type 2-1 fructans have some effect on the antibody response to seasonal influenza vaccination in healthy middle-aged humans. Nutr. Immunol. 2015, 6, 490. [CrossRef] [PubMed]
93. Langkamp-Henken, B.; Bender, B.S.; Gardner, E.M.; Herrlinger-Garcia, K.A.; Kelley, M.J.; Murasko, D.M.; Schaller, J.P.; Stechmiller, J.K.; Thomas, D.J.; Wood, S.M. Nutritional formula enhanced immune function and reduced days of symptoms of upper respiratory tract infection in seniors. J. Am. Geriatr. Soc. 2004, 52, 3-12. [CrossRef] [PubMed]
94. Vos, A.P.; Knol, J.; Stahl, B.; M’rabet, L.; Garssen, J. Specific prebiotic oligosaccharides modulate the early phase of a murine vaccination response. Int. Immunopharmacol. 2010, 10, 619-625. [CrossRef] [PubMed]
95. Samal, L.; Chaturvedi, V.B.; Saikumar, G.; Somvanshi, R.; Pattanaik, A.K. Prebiotic potential of Jerusalem artichoke (Helianthus tuberosus L.) inWistar rats: Effects of levels of supplementation on hindgut fermentation, intestinal morphology, blood metabolites and immune response. J. Sci. Food Agric. 2015, 95, 1689-1696. [CrossRef] [PubMed]
96. Ahmed, S.F.; Farheen, A.; Muzaffar, A.; Mattoo, G.M. Prevalence of diarrhoeal disease, its seasonal and age variation in under-fives in Kashmir, India. Int. J. Health Sci. 2008, 2, 126-133.
97. Saavedra, J.; Tschernia, A.; Moore, N.; Abi-Hanna, A.; Coletta, F.; Emenhiser, C.; Yolken, R. Gastro-intestinal function in infants consuming a weaning food supplemented with oligofructose, a prebiotic. J. Pediatr. Gastroenterol. Nutr. 1999, 29, 513. [CrossRef]
98. Tschernia, A.; Moore, N.; Abi-Hanna, A.; Yolken, R.; Coletta, F.; Emenhiser, C.; Saavedra, J. Effects of long-term consumption of a weaning food supplemented with oligofructose, a prebiotic, on general infant health status. J. Pediatr. Gastroenterol. Nutr. 1999, 29, 503. [CrossRef]
99. Osborn, D.A.; Sinn, J.K. Prebiotics in infants for prevention of allergy. Cochrane Database Syst. Rev. 2013, 3, CD006474. [PubMed]
100. Grüber, C.; van Stuijvenberg, M.; Mosca, F.; Moro, G.; Chirico, G.; Braegger, C.P.; Riedler, J.; Boehm, G.; Wahn, U. Reduced occurrence of early atopic dermatitis because of immunoactive prebiotics among low-atopy-risk infants. J. Allergy Clin. Immunol. 2010, 126, 791-797. [CrossRef] [PubMed]
101. Moro, G.; Arslanoglu, S.; Stahl, B.; Jelinek, J.; Wahn, U.; Boehm, G. A mixture of prebiotic oligosaccharides reduces the incidence of atopic dermatitis during the first six months of age. Arch. Dis. Child. 2006, 91, 814-819. [CrossRef] [PubMed]
102. Boyle, R.J.; Tang, M.L.; Chiang, W.C.; Chua, M.C.; Ismail, I.; Nauta, A.; Hourihane, J.O.; Smith, P.; Gold, M.; Ziegler, J. et al. Prebiotic-supplemented partially hydrolysed cow’s milk formula for the prevention of eczema in high-risk infants: A randomized controlled trial. Allergy 2016, 71, 701-710. [CrossRef] [PubMed]
103. Van Esch, B.C.; Schouten, B.; de Kivit, S.; Hofman, G.A.; Knippels, L.M.; Willemsen, L.E.; Garssen, J. Oral tolerance induction by partially hydrolyzed whey protein in mice is associated with enhanced numbers of Foxp3+ regulatory T-cells in the mesenteric lymph nodes. Pediatr. Allergy Immunol. 2011, 22, 820-826. [CrossRef] [PubMed]
104. Sprenger, N.; Odenwald, H.; Kukkonen, A.K.; Kuitunen, M.; Savilahti, E.; Kunz, C. FUT2-dependent breast milk oligosaccharides and allergy at 2 and 5 years of age in infants with high hereditary allergy risk. Eur. J. Nutr. 2016, 1-9. [CrossRef] [PubMed]
105. Kukkonen, K.; Savilahti, E.; Haahtela, T.; Juntunen-Backman, K.; Korpela, R.; Poussa, T.; Tuure, T.; Kuitunen, M. Probiotics and prebiotic galacto-oligosaccharides in the prevention of allergic diseases: A randomized, double-blind, placebo-controlled trial. J. Allergy Clin. Immunol. 2007, 119, 192-198. [CrossRef] [PubMed]
106. De Kivit, S.; Saeland, E.; Kraneveld, A.D.; van de Kant, H.J.; Schouten, B.; van Esch, B.C.; Knol, J.; Sprikkelman, A.B.; van der Aa, L.B.; Knippels, L.M. et al. Galectin-9 induced by dietary synbiotics is involved in suppression of allergic symptoms in mice and humans. Allergy 2012, 67, 343-352. [CrossRef] [PubMed]
107. Schouten, B.; van Esch, B.C.; Hofman, G.A.; Boon, L.; Knippels, L.M.; Willemsen, L.E.; Garssen, J. Oligosaccharide-induced whey-specific CD25(+) regulatory T-cells are involved in the suppression of cow milk allergy in mice. J. Nutr. 2010, 140, 835-841. [CrossRef] [PubMed]
108. Hogenkamp, A.; Thijssen, S.; van Vlies, N.; Garssen, J. Supplementing pregnant mice with a specific mixture of nondigestible oligosaccharides reduces symptoms of allergic asthma in male offspring. J. Nutr. 2015, 145, 640-646. [CrossRef] [PubMed]
109. Vos, A.P.; van Esch, B.C.; Stahl, B.; M’Rabet, L.; Folkerts, G.; Nijkamp, F.P.; Garssen, J. Dietary supplementation with specific oligosaccharide mixtures decreases parameters of allergic asthma in mice. Int. Immunopharmacol. 2007, 7, 1582-1587. [CrossRef] [PubMed]
110. Soh, J.Y.; Huang, C.H.; Chiang, W.C.; Llanora, G.V.; Lee, A.J.; Loh, W.; Chin, Y.L.; Tay, V.Y.; Chan, Y.H.; Dianne, D. et al. Anaphylaxis to galacto-oligosaccharides—An evaluation in an atopic population in Singapore. Allergy 2015, 70, 1020-1023. [CrossRef] [PubMed]
111. Toward, R.; Montandon, S.; Walton, G.; Gibson, G.R. Effect of prebiotics on the human gut microbiota of elderly persons. Gut Microbes 2012, 3, 57-60. [CrossRef] [PubMed]
112. Guigoz, Y.; Rochat, F.; Perruisseau-Carrier, G.; Rochat, I.; Schiffrin, E.J. Effects of oligosaccharide on the faecal flora and non-specific immune system in elderly people. Nutr. Res. 2002, 22, 13-25. [CrossRef]
113. Vulevic, J.; Drakoularakou, A.; Yaqoob, P.; Tzortzis, G.; Gibson, G.R. Modulation of the fecal microflora profile and immune function by a novel trans-galactooligosaccharide mixture (B-GOS) in healthy elderly volunteers. Am. J. Clin. Nutr. 2008, 88, 1438-1446. [PubMed]
114. Vulevic, J.; Juric, A.; Walton, G.E.; Claus, S.P.; Tzortzis, G.; Toward, R.E.; Gibson, G.R. Influence of galacto-oligosaccharide mixture (B-GOS) on gut microbiota, immune parameters and metabonomics in elderly persons. Br. J. Nutr. 2015, 114, 586-595. [CrossRef] [PubMed]
115. Asarat, M.; Apostolopoulos, V.; Vasiljevic, T.; Donkor, O. Short-chain fatty acids produced by synbiotic mixtures in skim milk differentially regulate proliferation and cytokine production in peripheral blood mononuclear cells. Int. J. Food Sci. Nutr. 2015, 66, 755-765. [CrossRef] [PubMed]
116. Valcheva, R.; Hotte, N.; Gillevet, P.; Sikaroodi, M.; Thiessen, A.; Madsen, K.L. Soluble dextrin fibers alter the intestinal microbiota and reduce proinflammatory cytokine secretion in male IL-10-deficient mice. J. Nutr. 2015, 145, 2060-2066. [CrossRef] [PubMed]
117. Brown, G.D.; Gordon, S. Immune recognition: A new receptor for -glucans. Nature 2001, 413, 36-37. [CrossRef] [PubMed]
118. Herre, J.; Gordon, S.; Brown, G.D. Dectin-1 and its role in the recognition of beta-glucans by macrophages. Mol. Immunol. 2004, 40, 869-876. [CrossRef] [PubMed]
119. Hong, K.B.; Jeong, M.; Han, K.S.; Kim, J.H.; Park, Y.; Suh, H.J. Photoprotective effects of galacto-oligosaccharide and/or Bifidobacterium longum supplementation against skin damage induced by ultraviolet irradiation in hairless mice. Int. J. Food Sci. Nutr. 2015, 66, 923-930. [CrossRef] [PubMed]
120. Kano, M.; Masuoka, N.; Kaga, C.; Sugimoto, S.; Iizuka, R.; Manabe, K.; Sone, T.; Oeda, K.; Nonaka, C.; Miyazaki, K. et al. Consecutive intake of fermented milk containing Bifidobacterium breve strain Yakult and galacto-oligosaccharides benefits skin condition in healthy adult women. Biosci. Microbiota Food Health 2013, 32, 33-39. [CrossRef] [PubMed]
121. Miyazaki, K.; Masuoka, N.; Kano, M.; Iizuka, R. Bifidobacterium fermented milk and galacto-oligosaccharides lead to improved skin health by decreasing phenols production by gut microbiota. Benef. Microbes 2014, 5, 121-128. [CrossRef] [PubMed]
122. Kawakami, K.; Makino, I.; Asahara, T.; Kato, I.; Onoue, M. Dietary galacto-oligosaccharides mixture can suppress serum phenol and p-cresol levels in rats fed tyrosine diet. J. Nutr. Sci. Vitaminol. 2005, 51, 182-186. [CrossRef] [PubMed]
123. Mozaffarian, D.; Benjamin, E.J.; Go, A.S.; Arnett, D.K.; Blaha, M.J.; Cushman, M.; Das, S.R.; de Ferranti, S.; Després, J.P.; Fullerton, H.J. et al. Heart disease and stroke statistics—2016 update. A report from the American heart association. Circulation 2015. [CrossRef] [PubMed]
124. Letexier, D.; Diraison, F.; Beylot, M. Addition of inulin to a moderately high-carbohydrate diet reduces hepatic lipogenesis and plasma triacylglycerol concentrations in humans. Am. J. Clin. Nutr. 2003, 77, 559-564. [PubMed]
125. Forcheron, F.; Beylot, M. Long-term administration of inulin-type fructans has no significant lipid-lowering effect in normolipidemic humans. Metabolism 2007, 56, 1093-1098. [CrossRef] [PubMed]
126. Russo, F.; Chimienti, G.; Riezzo, G.; Pepe, G.; Petrosillo, G.; Chiloiro, M.; Marconi, E. Inulin-enriched pasta affects lipid profile and Lp(a) concentrations in Italian young healthy male volunteers. Eur. J. Nutr. 2008, 47, 453. [CrossRef] [PubMed]
127. Brighenti, F. Dietary fructans and serum triacylglycerols: A meta-analysis of randomized controlled trials. J. Nutr. 2007, 137, 2552S-2556S. [PubMed]
128. Jackson, K.G.; Lovegrove, J.A. Impact of probiotics, prebiotics and synbiotics on lipid metabolism in humans. Nutr. Aging 2013, 1, 181-200.
129. Vogt, J.A.; Ishii-Schrade, K.B.; Pencharz, P.B.; Jones, P.J.; Wolever, T.M. L-rhamnose and lactulose decrease serum triacylglycerols and their rates of synthesis, but do not affect serum cholesterol concentrations in men. J. Nutr. 2006, 136, 2160-2166. [PubMed]
130. Jenkins, D.J.; Wolever, T.M.; Jenkins, A.; Brighenti, F.; Vuksan, V.; Rao, A.V.; Cunnane, S.C.; Ocana, A.; Corey, P.; Vezina, C. Specific types of colonic fermentation may raise low-density-lipoprotein-cholesterol concentrations. Am. J. Clin. Nutr. 1991, 54, 141-147. [PubMed]
131. Vulevic, J.; Juric, A.; Tzortzis, G.; Gibson, G.R. A mixture of trans-galactooligosaccharides reduces markers of metabolic syndrome and modulates the fecal microbiota and immune function of overweight adults. J. Nutr. 2013, 143, 324-331. [CrossRef] [PubMed]
132. Tiwari, U.; Cummins, E. Meta-analysis of the effect of-glucan intake on blood cholesterol and glucose levels. Nutrition 2011, 27, 1008-1016. [CrossRef] [PubMed]
133. Beynen, A.C.; Buechler, K.F.; Van der Molen, A.J.; Geelen, M.J. The effects of lactate and acetate on fatty acid and cholesterol biosynthesis by isolated rat hepatocytes. Int. J. Biochem. 1982, 14, 165-169. [CrossRef]
134. Wolever, T.M.; Brighenti, F.; Royall, D.; Jenkins, A.L.; Jenkins, D.J. Effect of rectal infusion of short chain fatty acids in human subjects. Am. J. Gastroenterol. 1989, 84, 1027-1033. [PubMed]
135. Mortensen, P.B.; Holtug, K.; Rasmussen, H.S. Short-chain fatty acid production from mono- and disaccharides in a fecal incubation system: Implications for colonic fermentation of dietary fiber in humans. J. Nutr. 1988, 118, 321-325. [PubMed]
136. Wolever, T.M.; Spadafora, P.J.; Cunnane, S.C.; Pencharz, P.B. Propionate inhibits incorporation of colonic [1,2-13C]acetate into plasma lipids in humans. Am. J. Clin. Nutr. 1995, 61, 1241-1247. [PubMed]
137. Tarantino, G.; Finelli, C. Systematic review on intervention with prebiotics/probiotics in patients with obesity-related nonalcoholic fatty liver disease. Future Microbiol. 2015, 10, 889-902. [CrossRef] [PubMed]
138. Lambert, J.E.; Parnell, J.A.; Eksteen, B.; Raman, M.; Bomhof, M.R.; Rioux, K.P.; Madsen, K.L.; Reimer, R.A. Gut microbiota manipulation with prebiotics in patients with non-alcoholic fatty liver disease: A randomized controlled trial protocol. BMC Gastroenterol. 2015, 15, 169. [CrossRef] [PubMed]